EMPLOYMENT AGREEMENTEmployment Agreement • April 4th, 2019 • Bison Capital Acquisition Corp. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”), with an Effective Date of January 1, 2019, is made by and between Xynomic Pharmaceuticals, Inc. (the “Company”) and Wentao Wu (the “Employee”).
THIRD AMENDMENT TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • April 4th, 2019 • Bison Capital Acquisition Corp. • Pharmaceutical preparations
This THIRD AMENDMENT TO AGREEMENT AND PLAN OF MERGER, is entered into as of April 2, 2019 (this “Amendment”), by and among Xynomic Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Bison Capital Acquisition Corp., a British Virgin Islands company limited by shares (“Parent”), Bison Capital Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent (the “Merger Sub”), and Yinglin Mark Xu (“XU”), an individual residing in Shanghai, China, solely in his capacity as the representative for the Company Stockholders (the “Stockholder Representative”).
LICENSE AGREEMENT between PHARMACYCLICS LLC and XYNOMIC PHARMACEUTICALS, INC. Dated as of February 23, 2017License Agreement • April 4th, 2019 • Bison Capital Acquisition Corp. • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”) is made and entered into effective as of February 23, 2017 (the “Effective Date”) by and between Pharmacyclics LLC, a Delaware limited liability company wholly owned by AbbVie Inc. (“Pharmacyclics”), and Xynomic Pharmaceuticals, Inc., a Wyoming corporation (“Xynomic”). Pharmacyclics and Xynomic are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
PATENT ASSIGNMENT AND LICENSING AGREEMENTPatent Assignment and Licensing Agreement • April 4th, 2019 • Bison Capital Acquisition Corp. • Pharmaceutical preparations • New York
This Patent Assignment and Licensing Agreement (“Agreement”) is entered into on the date of last signature hereto (“Effective Date”)
Labor Contract (Fixed term)Labor Contract • April 4th, 2019 • Bison Capital Acquisition Corp. • Pharmaceutical preparations
Both parties have signed this contract for joint observation according to the “Labor Law of the People’s Republic of China” and “Labor Contract Law of the People’s Republic of China” and relevant laws and regulations, and on an equal, voluntary and consensus basis.
LICENSE AGREEMENTLicense Agreement • April 4th, 2019 • Bison Capital Acquisition Corp. • Pharmaceutical preparations • New York
Boehringer Ingelheim International GmbH (“BII”), a German limited liability company, with offices at Binger Straße 173, 55216 Ingelheim am Rhein, Germany; and
Cooperative Development Agreement for New DrugsCooperative Development Agreement • April 4th, 2019 • Bison Capital Acquisition Corp. • Pharmaceutical preparations
In accordance with the Contract Law of the People’s Republic of China and other relevant laws, regulations, rules and policies, based on equal consultation, Party A and Party B have reached an agreement on cooperatively developing new drugs. Both parties are voluntary to sign this contract and would like to abide by all the provisions thereof.
